Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07730138
PHASE3

Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer

Sponsor: Daewoong Pharmaceutical Co. LTD.

View on ClinicalTrials.gov

Summary

A Multinational, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group, Phase 3 Study to Evaluate the Efficacy and Safety of DWP14012 in Participants with Gastric Ulcer

Official title: A Multinational, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group, Phase 3 Study to Evaluate the Efficacy and Safety of DWP14012 in Participants With Gastric Ulcer

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

384

Start Date

2026-10-15

Completion Date

2028-10-15

Last Updated

2026-07-28

Healthy Volunteers

No

Conditions

Interventions

DRUG

DWP14012 40mg (Fexuprazan)

DWP14012 40mg(Fexuprazan) + placebo of Lansoprazole

DRUG

Lansoprazole 30mg

Lansoprazole 30mg + Placebo of DWP14012 40mg

Locations (2)

RS Cipto Mangunkusumo

Jakarta, Indonesia

The Catholic University of Korea, Incheon St. Mary'S Hospital

Incheon, South Korea